Meet the Investigator: Rebecca Haberman

Share on social media

Rebecca Haberman, MD

NYU Grossman School of Medicine

Scientist Development Award

COVID-19 in Patients with Inflammatory Arthritis: A Prospective Study on the Effects of Immunomodulatory Therapy on Susceptibility and Clinical Outcomes

Dr. Haberman is researching the impact of COVID-19 in patients with autoimmune diseases as well as the effectiveness of the COVID-19 vaccinations in the patient population.

“We hope that our project will empower patients to know more about their health in terms of COVID-19 and really encourage them to get vaccinated appropriately.”

To hear more from Dr. Haberman, watch the video above.

Donors like you make our important research funding possible. Consider donating today.